{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T15:07:34Z","timestamp":1792595254786,"version":"4.5.0"},"reference-count":39,"publisher":"Informa UK Limited","issue":"2","content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Expert Review of Anticancer Therapy"],"published-print":{"date-parts":[[2020,2,1]]},"DOI":"10.1080\/14737140.2020.1724097","type":"journal-article","created":{"date-parts":[[2020,1,31]],"date-time":"2020-01-31T10:41:51Z","timestamp":1580467311000},"page":"131-136","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":15,"title":["The potential of BRAF-targeted therapy combined with immunotherapy in melanoma"],"prefix":"10.1080","volume":"20","author":[{"given":"Sheida","family":"Naderi-Azad","sequence":"first","affiliation":[{"name":"University of Toronto Faculty of Medicine, Toronto, Ontario"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryan","family":"Sullivan","sequence":"additional","affiliation":[{"name":"Center for Melanoma, Massachusetts General Hospital Cancer Center, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2020,2,5]]},"reference":[{"key":"CIT0001","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1904059"},{"key":"CIT0002","doi-asserted-by":"publisher","DOI":"10.1111\/pcmr.12098"},{"key":"CIT0003","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(16)30122-X"},{"key":"CIT0004","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(18)30142-6"},{"key":"CIT0005","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(14)70012-9"},{"key":"CIT0006","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(12)60868-X"},{"key":"CIT0007","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(18)30940-9"},{"key":"CIT0008","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1003466"},{"key":"CIT0009","author":"Sharp M","year":"2013","journal-title":"Clin Trial"},{"key":"CIT0010","author":"Squibb BM.","year":"2012","journal-title":"Clin Trial"},{"key":"CIT0011","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(18)30700-9"},{"key":"CIT0012","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1103782"},{"key":"CIT0013","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1203421"},{"key":"CIT0014","first-page":"NCT02631447","author":"Onlus FM","year":"2019","journal-title":"Clin Trial"},{"key":"CIT0015","first-page":"NCT02224781","author":"National Cancer Institute","year":"2014","journal-title":"Clin Trial"},{"key":"CIT0016","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-10-0118"},{"key":"CIT0017","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-12-1630"},{"key":"CIT0018","doi-asserted-by":"publisher","DOI":"10.1158\/2326-6066.CIR-15-0030"},{"key":"CIT0019","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/djv435"},{"key":"CIT0020","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-16-1688"},{"key":"CIT0021","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2013.52.1377"},{"key":"CIT0022","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-11-2837"},{"key":"CIT0023","doi-asserted-by":"publisher","DOI":"10.4161\/onci.24320"},{"key":"CIT0024","doi-asserted-by":"publisher","DOI":"10.1080\/2162402X.2016.1238557"},{"key":"CIT0025","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-12-1626"},{"key":"CIT0026","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-11-2479"},{"key":"CIT0027","doi-asserted-by":"publisher","DOI":"10.1172\/JCI66236"},{"issue":"7","key":"CIT0028","first-page":"00","volume":"5","author":"Moreno BH","year":"2015","journal-title":"Oncoimmunology"},{"key":"CIT0029","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-16-0906"},{"key":"CIT0030","doi-asserted-by":"publisher","DOI":"10.1186\/s40425-018-0387-x"},{"issue":"5","key":"CIT0031","first-page":"e1423172","volume":"7","author":"Mooradian MJ","year":"2018","journal-title":"Onco immunol"},{"key":"CIT0032","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMc1302338"},{"key":"CIT0033","doi-asserted-by":"publisher","DOI":"10.1200\/jco.2014.32.15_suppl.2511"},{"key":"CIT0034","doi-asserted-by":"publisher","DOI":"10.1111\/pcmr.12383"},{"key":"CIT0035","first-page":"930","volume":"25","author":"Ribas A","year":"2019","journal-title":"Nat Med"},{"key":"CIT0036","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-019-0448-9"},{"key":"CIT0037","volume-title":"Updated survival in patients with BRAF-mutant melanoma administered pembrolizumab, dabrafenib and trametinib","author":"Ferrucci PF","year":"2019"},{"key":"CIT0038","volume-title":"The anti-PD1 antibody spartalizumab in combination with dabrafenib and trametinib in previously untreated patients with advanced BRAF V600-mutant melanoma: updated efficacy and safety from parts 1 and 2 of COMBI-i.","author":"Long GV","year":"2019"},{"key":"CIT0039","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-019-0474-7"}],"container-title":["Expert Review of Anticancer Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/14737140.2020.1724097","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,2,20]],"date-time":"2020-02-20T10:30:49Z","timestamp":1582194649000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/14737140.2020.1724097"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,2,1]]},"references-count":39,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2020,2,1]]}},"alternative-id":["10.1080\/14737140.2020.1724097"],"URL":"https:\/\/doi.org\/10.1080\/14737140.2020.1724097","relation":{},"ISSN":["1473-7140","1744-8328"],"issn-type":[{"value":"1473-7140","type":"print"},{"value":"1744-8328","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,2,1]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=iery20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=iery20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2019-09-02","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-01-28","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-02-05","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}